Genentech Scientists Zero in on “Liquid Biopsies” as a Way to Replace Tissue Biopsies in Breast Cancer

Surgical pathologists could gain new tool to diagnose many types of cancers It might soon be possible to determine the HER2 status of breast cancer patients from blood samples rather than tissue biopsies. If this new technology proves feasible, it would give surgical pathologists and medical laboratories a different, and possibly less complex, methodology to use when assessing a case of breast cancer. In its report about the study, Medscape Medical News, wrote that “HER2 status derived from...

Duke University Study Suggests Gene Patents Don’t Advance Care for Patients

Pathologists already find it difficult to obtain gene patent licenses needed to offer multi-gene molecular diagnostic tests Patents on human genes are a major issue in pathology and clinical laboratory testing. Now a new report based on the study of the positive and negative consequences of gene patenting comes to the conclusion that patents on human genes tend to deter competition in the gene testing market more than they encourage further development of new technologies for measuring the...
;